Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s recently reformed committee on compounding pharmacies will meet this week to discuss adding more peptides to the list of substances that pharmacies can produce. But industry observers are conflicted over treating peptides — which Kennedy has said he's a "big fan of" — like pharmaceuticals. The Pharmacy Compounding Advisory...
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s recently reformed committee on compounding pharmacies will meet this week to discuss adding more peptides to the list of substances that pharmacies can produce. But industry observers are conflicted over treating peptides — which Kennedy has said he's a "big fan of" — like pharmaceuticals. The Pharmacy Compounding Advisory...
<iframe src="https://statesidedaily.com/embed/cluster/17a367d83deced8c6fdf0da1b08fe9245169ec65" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Upcoming FDA peptide meeting puts industry on edge"></iframe>
